Structural Analysis of 5-aminosalicyl-L-glutamic Acid, a Colon-specific Prodrug of 5-aminosalicylic Acid, for Colon-specific Deconjugation |
Kim, Ji-Hye
(College of Pharmacy, Pusan National University)
Kim, Jung-Yoon (College of Pharmacy, Pusan National University) Lee, Yong-Hyun (College of Pharmacy, Pusan National University) Kim, Young-Mi (College of Pharmacy, Pusan National University) Jung, Yun-Jin (College of Pharmacy, Pusan National University) |
1 | Kim, H., Kong, H., Choi, B., Yang, Y., Kim, Y., Lim, M.J., Neckers, L., Jung, Y., 2005. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease, Pharm Res. 22(9), 1499-1509. DOI |
2 | Lofberg, R., 2003. Review article: medical treatment of mild to moderately active Crohn's disease, Aliment Pharmacol Ther. 17 Suppl 2 18-22. |
3 | Novis, B.H., Korzets, Z., Chen, P., Bernheim, J., 1988. Nephrotic syndrome after treatment with 5-aminosalicylic acid, Br Med J (Clin Res Ed). 296(6634), 1442. |
4 | Sinha, V.R., Kumria, R., 2001. Polysaccharides in colon-specific drug delivery, Int J Pharm. 224(1-2), 19-38. DOI |
5 | Sinha, V.R., Kumria, R., 2001. Colonic drug delivery: prodrug approach, Pharm Res. 18(5), 557-564. DOI |
6 | Sinha, V.R., Kumria, R., 2003. Microbially triggered drug delivery to the colon, Eur J Pharm Sci. 18(1), 3-18. DOI |
7 | Van den Mooter, G., 2006. Colon drug delivery, Expert Opin Drug Deliv. 3(1), 111-125. DOI |
8 | Chourasia, M.K., Jain, S.K., 2003. Pharmaceutical approaches to colon targeted drug delivery systems, J Pharm Pharmaceut Sci. 6(1), 33-66. |
9 | Crotty, B., Jewell, D.P., 1992. Drug therapy of ulcerative colitis, Br J Clin Pharmacol. 34(3), 189-198. DOI ScienceOn |
10 | Jung, Y.J., Lee, J.S., Kim, Y.M., 2001. Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid, J Pharm Sci. 90(11), 1767-1775. DOI |
11 | Jung, Y.J., Lee, J.S., Kim, Y.M., 2000. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid, J Pharm Sci. 89(5), 594-602. DOI |